NYMC’s CRISPR Rapidly Identifies Lethal Candida auris
NYMC developed a CRISPR platform for rapid Candida auris detection, a lethal hospital-acquired fungus. This innovation promises faster isolation, preventing outbreaks and saving lives.
NYMC developed a CRISPR platform for rapid Candida auris detection, a lethal hospital-acquired fungus. This innovation promises faster isolation, preventing outbreaks and saving lives.